✦ LIBER ✦

Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease

✍ Scribed by Marta Krejci; Michael Doubek; Tomas Buchler; Yvona Brychtova; Jiri Vorlicek; Jiri Mayer

Publisher: Springer
Year: 2005
Tongue: English
Weight: 82 KB
Volume: 84
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-005-1070-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Infliximab treatment for steroid-refract

Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: A case report

✍ Gaël Piton; Fabrice Larosa; Anne Minello; Marie-Claude Becker; Georges Mantion; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Acute graft-versus-host disease (GVHD) following orthotopic liver transplantation is a rare but severe disease with a 75% death rate in adults. Various therapeutic strategies have been proposed for steroid-refractory GVHD, but there is still no consensus. Tumor necrosis factor-alpha is a key inflamm

Intra-arterial methylprednisolone for th

Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease

✍ Laurie A. Milner; Michael W. Becker; Steven H. Bernstein; Lauren Bruckner; Jonat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Staging System and chromosomal abnormalities determined by standard metaphase karyotype and/or fluorescence in situ hybridization (FISH). Treatment-induced adverse events were graded according to the National Cancer Institute common terminology criteria for adverse events (CTCAE) version 4.0. For r

Role of intra-arterial steroid administr

Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease

✍ Arafat Tfayli; George Selby; Feroz Maqbool; Walter Bierbaum; Mehdi Hamadani 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB 👁 2 views

## Abstract We report here a case of severe steroid‐refractory gastrointestinal graft‐versus‐host disease treated with intra‐arterial administration of corticosteroids. A 53‐year‐old female with non‐Hodgkin's lymphoma received peripheral blood hematopoietic stem cell transplant from her HLA‐matched

Low-Dose Antithymocyte Globulin for Trea

Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease

✍ Kazuteru Ohashi; Yuji Tanaka; Shin-ichiro Mori; Yoshiki Okuyama; Kiyoshi Hiruma; 📂 Article 📅 2003 🏛 Carden Jennings Publishing 🌐 English ⚖ 96 KB

High dose bolus methylprednisolone for t

High dose bolus methylprednisolone for the treatment of acute graft versus host disease

✍ Bacigalupo, Andrea ;Lint, Maria T. ;Frassoni, Francesco ;Podesta, Marina ;Venezi 📂 Article 📅 1983 🏛 Springer-Verlag ⚖ 508 KB

Nineteen patients with acute graft versus host disease (GvHD) following bone marrow transplantation (BMT) were treated with high dose bolus 6-methylprednisolone (BMPr), at the dose of 20 mg/kg/day i.v. for the first 3 days, 10 mg/kg/day i.v. for the following 4 days, and then at doses gradually tape

Anti-LFA1 monoclonal antibody (25.3) for

Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III–IV acute graft-versus-host disease

✍ A. M. Stoppa; D. Maraninchi; D. Blaise; P. Viens; M. Hirn; D. Olive; J. Reiffers 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 537 KB

The in vivo efficacy of 25.3 monoclonal antibody (mAb) directed against human LFA1 molecule was assessed in ten patients with steroid-resistant grade III-IV acute graft-versus-host disease (AGVHD). These patients received non-T-cell-depleted allogeneic bone marrow transplantation for aplastic anemia